The Highest Standard in Peptide Research.

Bodytide Wellness Lab
WEIGHT MANAGEMENT & METABOLIC OPTIMISATION

ADIPOTIDE 30MG

Targeted fat loss and weight reduction

Adipotide (FTPP) is an investigational peptidomimetic engineered to target the blood supply of white adipose tissue, initiating selective fat cell clearance.

ADIPOTIDE 30MG
£153.00

Active Ingredient: 30.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Current batch fully reserved. Next allocation underway.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Targeted Weight Reduction: Promotes direct volume loss in white subcutaneous and visceral fat deposits.
Insulin Sensitivity Support: Reduces systemic adipose tissue volume, supporting healthy metabolic parameters.
Rapid Lipid Mobilisation: Signals the body to mobilize and process stored fatty acids.
Metabolic Re-alignment: Supports significant shifts in body composition during intensive research protocols.
Adipose Vascular Clearance: Selectively binds to blood vessels supplying white adipose tissue, reducing blood flow to fat stores.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is ADIPOTIDE 30MG?

Adipotide is a synthetic pro-apoptotic peptide designed to target the vascular bed of white fat tissue. By binding specifically to prohibitin proteins expressed on the blood vessel surfaces of adipose tissue, the peptide disrupts blood supply to fat cells, causing them to undergo natural apoptosis and subsequent resorption by the body.

The Cellular Mechanism

Prohibitin Targeting: Binds selectively to prohibitin receptors on vascular endothelial cells supplying white fat tissue.
Mitochondrial Membrane Disruption: Delivers a pro-apoptotic formula that disrupts endothelial cell mitochondria, shutting down blood supply to white fat.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 500mcg to 1mg daily. To allow cellular receptors and renal pathways to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1-2 (Baseline Priming): An initial daily dose of 500mcg (5 clicks once per day).

Weeks 2 Onwards (Active Titration): The protocol scales to 1mg daily (10 clicks once per day).

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Renal Hydration Need: Temporary changes in renal filtration parameters; maintaining high daily fluid intake is essential during research protocols.
Injection Site Sensitivity: Minor, transient redness or mild warmth at the application site.